We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

000720:KRXHyundai Engineering & Construction Co.,Ltd. Analysis

Data as of 2026-03-11 - not real-time

₩148,800.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Technical momentum remains bullish as the stock trades above its short‑term and mid‑term moving averages, supported by an increasing volume trend and a price that sits in the upper half of the RSI range. However, the MACD histogram has turned negative, signalling a potential short‑term bearish divergence, and analyst price targets are currently set below the market level, implying limited upside.
Fundamentally, the company appears cheap with a forward PE comfortably lower than the sector average and a modest price‑to‑sales multiple, yet it is burdened by a very high debt load, negative cash‑flow generation and a negative return on equity, raising concerns about earnings sustainability and dividend coverage. Recent news of a Q4 profit swing offers a glimmer of turnaround, but the balance sheet and cash‑flow profile remain weak, suggesting that any upside may be constrained in the near term while long‑term structural demand for infrastructure could provide a catalyst if financial discipline improves.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 8/10

Key Factors

  • price above moving averages but MACD bearish divergence
  • analyst targets below current price indicating limited upside
  • high short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • recent profit turnaround in Q4
  • valuation multiples remain attractive relative to peers
  • persistent debt and cash‑flow weakness

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • exposure to long‑term infrastructure projects across multiple regions
  • low beta suggesting lower market‑wide risk over time
  • potential for improved earnings and dividend sustainability if balance sheet is restructured

Key Metrics & Analysis

Financial Health

Revenue Growth-5.20%
Profit Margin-0.88%
P/E Ratio22.3
ROE-7.43%
ROA-3.18%
Debt/Equity39.89
Op. Cash Flow₩-1807155986432
Free Cash Flow₩-1229139869696
Industry P/E29.3

Technical Analysis

TrendBullish
RSI59.0
Support₩102,300.00
Resistance₩176,900.00
MA 20₩135,545.00
MA 50₩109,666.00
MA 200₩76,182.50
MACDBearish
VolumeIncreasing
Fear & Greed Index78.07

Valuation

Target Price₩139,631.58
Upside/Downside-6.16%
GradeUndervalued
TypeValue
Dividend Yield0.53%

Risk Assessment

Beta0.49
Volatility100.40%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.